Pharmaceuticals Businesses for Sale and Investment

Operates a pharmaceutical manufacturing company based in Mumbai. - Owns and manages a portfolio of nearly 80 pharmaceutical brands, including trademarked and copyright-protected names. - Acts as a third-party manufacturer for different brands. - Product portfolio spans gynecology, respiratory care, and cardiovascular disease segments. - Maintains an active distribution network of approximately 50–60 distributors across multiple regions. - Revenue decline occurred recently due to working capital constraints, limiting the ability to execute purchase orders. - Supported by a lean team of 5 employees handling marketing, coordination, and distributor management. - Monthly sales have declined compared to last year due to insufficient working capital, which limited the ability to process purchase orders and impacted overall sales. - We are a USFDA company.

The company is currently non-operational. - It previously sold generic pharmaceutical medicines in liquid and tablet forms to treat cold, fever, and cough. - Operations were discontinued this year as the owner decided to sell the business. - Revenue was generated through sales to B2B customers. - Manufacturing was outsourced to an OEM partner. - The business is registered as an LLC and holds a valid pharmaceutical license.

The company is currently non-operational. - It previously sold generic pharmaceutical medicines in liquid and tablet forms to treat cold, fever, and cough. - Operations were discontinued this year as the owner decided to sell the business. - Revenue was generated through sales to B2B customers. - Manufacturing was outsourced to an OEM partner. - The business is registered as an LLC and holds a valid pharmaceutical license.

The company is in the pre-revenue phase and plans to manufacture Ayurvedic and nutraceutical products. - Production will be carried out through two OEM manufacturers. - The planned revenue model includes B2B sales to distributors as well as B2C sales through third-party e-commerce platforms such as Amazon and Flipkart. - The company is incorporated as a private limited entity and is registered under GST.

Located in Pimpri-Chinchwad, this pharma marketing business specializes in tailored solutions for the pharmaceutical and chemical manufacturing sectors. - The company procures and markets products, primarily enhancing brand visibility and accessibility within the pharma and chemical industries. - Partnerships with over 15 esteemed clients, including Cipla, Emcure, and Thermax, highlight the business's strong market presence and reliability. - As a channel partner for respected brands like Merck and Sigma-Aldrich, the company boosts its credibility within the scientific community. - Revenue is generated through the procurement and resale of pharmaceutical, chemical, and laboratory products to pharmaceutical and chemical manufacturers, R&D laboratories, and academic institutions. - Their primary customers are pharmaceutical and chemical manufacturers, research labs, and academic institutions in the Hinjewadi region of Pune. - With established relationships and competitive pricing, the company ensures reliable supply chain solutions, fostering customer loyalty. - The strategic location in Pune positions the business to capitalize on the increasing demand for innovative solutions from local research and manufacturing entities.

Proposed pharmaceutical marketing startup focused on medicines, dietary supplements, and medical devices. - Planned operations based in Tbilisi, targeting pharmacy-led and doctor-referred demand. - Business will collaborate with European manufacturers to import and market approved products locally. - Revenue model centered on pharma marketing and distribution rather than in-house manufacturing. - Sales and promotion will be driven by medical representatives engaging doctors and pharmacies. - Currently at ideation and setup stage with no commercial operations or revenue. - Legal structure planned as a Limited Liability Company (LLC). - Promoted by a founder with over a decade of experience in the pharmaceutical industry. - The founder has previously built and scaled another pharmaceutical company and continues to operate it. - The business is not yet registered.

Located in Carenage, Trinidad, this business specializes in wholesale distribution of pharmaceutical and medicine supplies. - Serves a growing network of 70 pharmacies across Trinidad, ensuring consistent service and customer loyalty. - Utilizes a wholesale distribution revenue model, driving profitability through bulk sales to pharmacies. - Imports stock primarily from China, ensuring a diverse range of products at competitive prices. - Supplies pharmacies on a weekly basis, maintaining timely delivery and stock availability for clients. - Leveraging practical experience in pharmaceutical distribution, supplier sourcing, and client management, the promoter maintains established relationships with both pharmacies and suppliers. - The business also provides on‑demand home healthcare services for seniors, adults, and busy families on a small, inconsistent scale, while the majority of revenue comes from pharmaceutical wholesale distribution. - Business is registered as a Private Limited entity, no industry-specific licenses or certifications are necessary, streamlining operations and reducing barriers to entry.

The company is in the pre-revenue phase and completed construction of its manufacturing facility this year. - The facility is approved by the WHO-GMP and the Indian FDA. - It is equipped with the necessary machinery to manufacture specialty pharmaceutical products. - The product range includes tablets, ointments, and liquid formulations. - The annual production capacity for tablets is 36 tons. - The liquid and ointment lines have a combined capacity of 800 litres per day. - The new investor can design a revenue model based on B2B sales through distributors. - The company is registered as a private limited entity and holds valid GST and MSME registrations.

The business operates in the pharma marketing and medical tourism sectors, offering a blend of healthcare services and pharmaceutical products. - As a licensed pharmaceutical company based in Chandrapur, it ensures compliance with industry standards and regulations for quality and safety. - It collaborates with third-party manufacturers to produce a variety of pharmaceutical products, leveraging external capabilities while maintaining brand integrity. - Products are marketed and sold under the company's own brand name, enhancing brand recognition and customer loyalty. - Recently, the company expanded into medical tourism, providing patients with comprehensive care options that include travel arrangements and medical services. - The company has successfully established a network with more than 50 B2B clients, facilitating partnerships that enhance its market reach. - Revenue is generated through diverse streams, including pharmaceutical product sales and medical tourism packages, catering to both local and international clients. - Operates with a valid GST certificate.

Operates a pharmaceutical marketing business focused on prescription-driven sales across multiple headquarters. - Products are promoted strictly through doctor prescriptions, covering therapeutic segments such as cough & cold, pain management, antibiotics, respiratory care, and nutritional supplements. - Backed by 20–25 years of promoter experience in the pharmaceutical marketing and prescription-sales ecosystem. - Maintains strong relationships with doctors and healthcare professionals, enabling consistent prescription generation. - Partnered with 7 distributors who regularly procure and supply the products, ensuring steady secondary sales. - Operates under a marketing-led pharma model without manufacturing, allowing lean operations and scalability. - Holds valid GST registration and is registered with the MCA, ensuring compliant and structured business operations.

Tech-enabled B2B pharmaceutical distribution platform, focusing on simplifying pharmacy procurement from over 50 distributors. - 2,000+ pharmacies served till date. - Revenue model: 8-10% EBITDA margin on B2B sales, projected to grow. - Promoters: Founder (Forbes 30 under 30 Asia, IIT Bombay, Y-Combinator) and Co-Founder (25 years pharma distribution experience). - Backed by Bluewatch Ventures, Soma Capital, Enrission India Capital, and Goodwater. - $4.2M seed funding raised (3 years ago). - 150+ pharma brands integrated. - Business has a registration and distribution license.

This global biotechnology company specializes in cutting-edge allogeneic adult stem cell technology, uniquely positioned as the only FDA-approved entity worldwide, with the Drug Controller General of India (DCGI) approval in process. - The company manufactures clinical-grade stem cells under cGMP standards, providing vital materials for US-based and international clinical trials, hence establishing a strong foothold in the biotechnology sector. - With Investigational New Drug Approvals for several serious conditions, including acute myocardial infarction, chronic heart failure, and Alzheimer’s disease, the company focuses on innovative solutions for chronic ailments lacking effective treatments. - Its cell-based therapies are designed to enhance longevity and quality of life, particularly targeting rehabilitation for chronic stroke patients and those affected by diseases without available cures. - Operating for 24 years in California, the business has a robust track record and is actively seeking expansion opportunities in international markets, allowing for broader reach and impact. - Revenue is generated through multiple channels, including a sale of license model with annual royalty fees averaging around 15% revenue, alongside direct sales of stem cells to existing licensees that partner with hospitals and healthcare providers. - Major license sale deals over the years include up to $529 million with South Asian countries, $72 million with a Chinese firm, $21 million with a Mexican company, $20 million with a Russian entity, and $21 million with a Kazakh company, showcasing strong demand and financial viability. - As a result of focused and aggressive marketing efforts to sell licenses, our sales have increased by a wide margin. We expect to reach an annual turnover of USD 3 billion for the next CY. - Recently registered as a public limited company in India, the firm is planning to establish a local laboratory and operations, further strengthening its market presence in the biotechnology industry. - The workforce comprises around 50 full-time employees, supplemented by freelance and interns, enhancing operational flexibility and innovation in research and development. - The promoter is currently in India and oversees operations across both locations.